Regen BioPharma, Inc. (OTCQB:RGBP) (OTCQB:RGBPP)
#Cancers #Lupus #Crohns #UlcerativeColitis
#RGBP Examines Utilizing Cannabidiols (CBD's)
Small Molecule Research May Provide Dynamic Therapy for Pain Management of IBD & Other Autoimmune Diseases.
Currently There are No Non Steroidal Therapies for IBD ($108 Billion Market).
Previous Trials Have Also Shown Success Treating Auto Immunes-The Reduction of Tumors & Potential Cancer Killing Effects.
Today's Economic Calendar
Responding to reports of a possible trade detente between the U.S. and China, stocks across the globe are continuing their climb higher. On Thursday, the WSJ quoted Treasury Secretary Steven Mnuchin as saying Washington could ease tariffs on Beijing, although the suggestion faced pushback from U.S. Trade Representative Robert Lighthizer. Earnings season remains in full swing, and investors today will also be watching figures on U.S. industrial production and consumer sentiment.
"Out of consideration for the 800,000 great American workers not receiving pay and to ensure his team can assist as needed, President Trump has canceled his Delegation's trip to the World Economic Forum in Davos, Switzerland," Press Secretary Sarah Sanders said in a statement. Trump had already scrapped his own trip, but Steven Mnuchin, Mike Pompeo, Wilbur Ross, Robert Lighthizer and Chris Liddell were supposed to attend the meeting.
"The journey to a balanced oil market will take time, and is more likely to be a marathon than a sprint," according to the IEA's closely watched monthly report. Production cuts by OPEC and Russia are being offset by swelling U.S. shale oil supply and an uncertain demand outlook. In fact, the U.S. in 2019 "will reinforce its leadership as the world's number one crude producer."